StockData
X4 Pharmaceuticals, Inc logo

X4 Pharmaceuticals, Inc (XFOR) stock

XFORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 3/30
$3.00+0.04 (+1.35%)

Close on Nov 20, 2026Market cap $297.44MP/E –Yield –

X4 Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

X4 Pharmaceuticals's revenue for the twelve months ending Sep 30, 2026 was $9.90M, up 73.7% year over year. For fiscal 2025 it was $6.50M, up 150.0% from the year before. The highest annual figure on record is $6.50M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.50M+150.0%
FY2024Dec 31, 2024$2.60M–
FY2023Dec 31, 2023$0–
FY2022Dec 31, 2022$0–
FY2021Dec 31, 2021$0-100.0%
FY2020Dec 31, 2020$3.00M–
FY2019Dec 31, 2019$0–
FY2018Dec 31, 2018$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.80M+75.0%
Q2 FY2026Jun 30, 2026$2.40M+41.2%
Q1 FY2026Mar 31, 2026$2.50M+177.8%
Q4 FY2025Dec 31, 2025$2.20M+46.7%
Q3 FY2025Sep 30, 2025$1.60M+185.7%
Q2 FY2025Jun 30, 2025$1.70M+202.0%
Q1 FY2025Mar 31, 2025$900.00K–
Q4 FY2024Dec 31, 2024$1.50M–
Q3 FY2024Sep 30, 2024$560.00K–
Q2 FY2024Jun 30, 2024$563.00K–
Q1 FY2024Mar 31, 2024$0–
Q2 FY2023Jun 30, 2023$0–
Q4 FY2021Dec 31, 2021$0–
Q3 FY2021Sep 30, 2021$0–
Q2 FY2021Jun 30, 2021$0–
Q1 FY2021Mar 31, 2021$0-100.0%
Q4 FY2020Dec 31, 2020$0–
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$0–
Q1 FY2020Mar 31, 2020$3.00M–
Q4 FY2019Dec 31, 2019$0-100.0%
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$0–
Q1 FY2019Mar 31, 2019$0–
Q4 FY2018Dec 31, 2018$3.50M–

More X4 Pharmaceuticals figures

See a number that looks wrong?